Drugs used for weight loss like Wegovy,Crypen Ozempic and Mounjaro are nearly everywhere in popular culture, but many patients struggling with obesity are still finding them hard to get. On today's show, what's slowing access to these drugs despite their long-term benefits for the economy and patients, and how social conditioning around obesity and excess weight clouds the conversation.
Related Episodes:
New drugs. Cheaper drugs. Why not both? (Apple / Spotify)
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
Music by Drop Electric. Find us: TikTok, Instagram, Facebook, Newsletter.
2025-05-05 23:581239 view
2025-05-05 23:512928 view
2025-05-05 23:32709 view
2025-05-05 22:152026 view
2025-05-05 22:12751 view
2025-05-05 22:06647 view
NEW YORK — Holiday sights and sounds fill Manhattan this time of year, from ice skating at Rockefell
LOS ANGELES (AP) — Los Angeles County and city will spend billions of dollars to provide more housin
White employees at Tesla have hurled racist slurs at Black co-workers inside the automaker's factory
